A review of adenoid cystic carcinoma of the breast with emphasis on its molecular and genetic characteristics

被引:34
作者
Vranic, Semir [1 ]
Bender, Richard [2 ]
Palazzo, Juan [3 ]
Gatalica, Zoran [2 ]
机构
[1] Univ Sarajevo, Dept Pathol, Ctr Clin, Sarajevo 71000, Bosnia & Herceg
[2] Caris Life Sci, Phoenix, AZ 85040 USA
[3] Jefferson Med Coll, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA
关键词
Breast cancer; Triple-negative breast carcinoma; Special types; Adenoid cystic carcinoma; GROWTH-FACTOR RECEPTOR; ESTROGEN-RECEPTORS; HIGH-FREQUENCY; C-KIT; BASAL; CANCER; EXPRESSION; PATHWAY; MYB; PTEN;
D O I
10.1016/j.humpath.2012.01.002
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Breast carcinomas that do not express estrogen receptor alpha, progesterone receptor, or human epidermal growth factor receptor 2 are frequently grouped together as "triple negative" and considered an aggressive type of breast malignancy; however, this group is not homogeneous. Adenoid cystic carcinoma of the breast is a rare type of breast cancer with such triple-negative features and, generally, a more favorable clinical course. This comprehensive review describes diagnostic, molecular, and clinical features of adenoid cystic carcinoma and compares them with those of triple-negative breast carcinomas of no special type. (c) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:301 / 309
页数:9
相关论文
共 102 条
[1]  
Alis H, 2008, CAN J SURG, V51, pE36
[2]  
[Anonymous], 2007, BIOL CANC
[3]  
[Anonymous], CANCER
[4]   Adenoid cystic carcinoma of the breast - Molecular markers, treatment, and clinical outcome [J].
Arpino, G ;
Clark, GM ;
Mohsin, S ;
Bardou, VJ ;
Elledge, RM .
CANCER, 2002, 94 (08) :2119-2127
[5]   KIT is highly expressed in adenoid cystic carcinoma of the breast, a basal-like carcinoma associated with a favorable outcome [J].
Azoulay, S ;
Laé, M ;
Fréneaux, P ;
Merle, S ;
Al Ghuzlan, A ;
Chnecker, C ;
Rosty, C ;
Klijanienko, J ;
Sigal-Zafrani, B ;
Salmon, R ;
Fourquet, A ;
Sastre-Garau, X ;
Vincent-Salomon, A .
MODERN PATHOLOGY, 2005, 18 (12) :1623-1631
[6]   Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists [J].
Badve, Sunil ;
Dabbs, David J. ;
Schnitt, Stuart J. ;
Baehner, Frederick L. ;
Decker, Thomas ;
Eusebi, Vincenzo ;
Fox, Stephen B. ;
Ichihara, Shu ;
Jacquemier, Jocelyne ;
Lakhani, Sunil R. ;
Palacios, Jose ;
Rakha, Emad A. ;
Richardson, Andrea L. ;
Schmitt, Fernando C. ;
Tan, Puay-Hoon ;
Tse, Gary M. ;
Weigelt, Britta ;
Ellis, Ian O. ;
Reis-Filho, Jorge S. .
MODERN PATHOLOGY, 2011, 24 (02) :157-167
[7]   Clinical significance of Myb protein and downstream target genes in salivary adenoid cystic carcinoma [J].
Bell, Diana ;
Roberts, Dianna ;
Karpowicz, Matthew ;
Hanna, Ehab Y. ;
Weber, Randal S. ;
El-Naggar, Adel K. .
CANCER BIOLOGY & THERAPY, 2011, 12 (07) :569-573
[8]   Loss of PTEN/MMAC1/TEP in EGF receptor-expressing tumor cells counteracts the antitumor action of EGFR tyrosine kinase inhibitors [J].
Bianco, R ;
Shin, I ;
Ritter, CA ;
Yakes, FM ;
Basso, A ;
Rosen, N ;
Tsurutani, J ;
Dennis, PA ;
Mills, GB ;
Arteaga, CL .
ONCOGENE, 2003, 22 (18) :2812-2822
[9]  
Blanco Mario, 2005, Ann Diagn Pathol, V9, P157, DOI 10.1016/j.anndiagpath.2005.02.008
[10]   Analysis of MYB expression and MYB-NFIB gene fusions in adenoid cystic carcinoma and other salivary neoplasms [J].
Brill, Louis B., II ;
Kanner, William A. ;
Fehr, Andre ;
Andren, Ywonne ;
Moskaluk, Christopher A. ;
Loening, Thomas ;
Stenman, Goran ;
Frierson, Henry F., Jr. .
MODERN PATHOLOGY, 2011, 24 (09) :1169-1176